Evidence map›Paper›PMID 25632141›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

The role of telomerase protein TERT in Alzheimer's disease and in tau-related pathology in vitro.

Alison Spilsbury, Satomi Miwa, Johannes Attems, Gabriele Saretzki

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 1 synthesis or guideline pooled it, 145 citations in OpenAlex.

  1. Meta-analysis of Telomere Length in Alzheimer's Disease.The journals of gerontology. Series A, Biological sciences and medical sciences · 2016
    Pooled it
  2. Review
  3. Article
  4. Telomerase mRNA-Lipid nanoparticles attenuate neuroinflammation after traumatic brain injury in mice.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. How to measure and model cardiovascular aging.Cardiovascular research · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alison SpilsburyNewcastle University Institute for Ageing, Campus for Ageing and Vitality, Institute for Cell and Molecular Bioscience, and.
Satomi MiwaNewcastle University Institute for Ageing, Campus for Ageing and Vitality, Institute for Cell and Molecular Bioscience, and.
Johannes AttemsNewcastle University Institute for Ageing, Campus for Ageing and Vitality, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
Gabriele SaretzkiNewcastle University Institute for Ageing, Campus for Ageing and Vitality, Institute for Cell and Molecular Bioscience, and gabriele.saretzki@newcastle.ac.uk.ORCID http://orcid.org/0000-0003-2100-8223
Newcastle Hospitals - Campus for Ageing and Vitality · GB

Funding

Medical Research Council G0400074Medical Research Council G0502157Medical Research Council G0900652Medical Research Council G1100540Medical Research Council MR/L016451/1The Dunhill Medical Trust SA15/1111
6 · The paper itself

Abstract

The telomerase reverse transcriptase protein TERT has recently been demonstrated to have a variety of functions both in vitro and in vivo, which are distinct from its canonical role in telomere extension. In different cellular systems, TERT protein has been shown to be protective through its interaction with mitochondria. TERT has previously been found in rodent neurons, and we hypothesize that it might have a protective function in adult human brain. Here, we investigated the expression of TERT at different stages of Alzheimer's disease pathology (Braak Stages I-VI) in situ and the ability of TERT to protect against oxidative damage in an in vitro model of tau pathology. Our data reveal that TERT is expressed in vitro in mouse neurons and microglia, and in vivo in the cytoplasm of mature human hippocampal neurons and activated microglia, but is absent from astrocytes. Intriguingly, hippocampal neurons expressing TERT did not contain hyperphosphorylated tau. Vice versa, neurons that expressed high levels of pathological tau did not appear to express TERT protein. TERT protein colocalized with mitochondria in the hippocampus of Alzheimer's disease brains (Braak Stage VI), as well as in cultured neurons under conditions of oxidative stress. Our in vitro data suggest that the absence of TERT increases ROS generation and oxidative damage in neurons induced by pathological tau. Together, our findings suggest that TERT protein persists in neurons of the adult human brain, where it may have a protective role against tau pathology.

Indexed as

AdolescentAdultAlzheimer DiseaseAnalysis of VarianceAnimalsAntigens, CDAntigens, Differentiation, MyelomonocyticCase-Control StudiesCD68 MoleculeCells, CulturedChildChild, PreschoolEmbryo, MammalianFemaleHippocampusHumansAntigens, CDAntigens, Differentiation, MyelomonocyticCD68 antigen, humanCD68 MoleculeMitochondrial ProteinsNerve Tissue ProteinsTelomeraseTERT protein, humanAlzheimer's diseasemitochondrianeuroprotectionoxidative stresstautelomerase

Identifiers

PMID25632141
PMCPMC4308607
OpenAlexW2005453919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.